Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-6

AIDS in South Africa: Therapeutic interventions to strengthen resilience among orphans and vulnerable children

Melissa Allen Heath, David R. Donald, Linda C. Theron [...]

School Psychology International

Retricted access

Research article

First published 2020-4

Does an Orphan Drug Policy Make a Difference in Access? A Comparison of Canada and Australia

Joel Lexchin, Nicholas Moroz

International Journal of Social Determinants of Health and Health Services

Retricted access

Editorial

First published 1968-12

Therapeutic Orphans—Everybody's Business

Harry C. Shirkey

Annals of Pharmacotherapy

Retricted access

Editorial

First published 2002-7

Severe,Acute Asthma as Therapeutic Orphan

H William Kelly

Annals of Pharmacotherapy

Open access

Research article

First published 2025-3

Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study

Joel Lexchin

JRSM Open

Retricted access

Research article

First published 1996-10

Introduction: Drug Development for Infants and Children: Rescuing the Therapeutic Orphan *

Gregory L. Kearns

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2010-2

Orphan drugs in haematology

Paola Zanon

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2018-1

Industry Perspective of Pediatric Drug Development in the United States

Taku Onishi, Katsura Tsukamoto, Naoki Matsumaru [...]

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2017-5

Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition

Ying Xu, Yan-Hui Ma, Ying-Xin Pang [...]

Tumor Biology

Retricted access

Research article

First published 2010-2

Designation,plausibility,protocol assistance,clinical benefit,similarity,reassessment: Rules and experiences

Chris Walker

Pharmaceuticals Policy and Law

Search results